ABBOTT LABORATORIES
ABTAbbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States (13% of 2024 revenues), diagnostic products (20% of 2024 revenues), nutritional products (22% of 2024 revenues), and medical devices (45% of 2024 revenues).
Drugs in Pipeline
140
Phase 3 Programs
89
Upcoming Catalysts
1
Next Catalyst
Oct 21, 2026
5wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Niacin extended-release (NER)
Dyslipidemia
Zemplar Capsule
Kidney Disease
clarithromycin extended-release tablets
Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).
Ritonavir
Sarcoma, Kaposi
Lopinavir/ritonavir
HIV Infections
Asoprisnil
Uterine Fibroids
Adalimumab 80 mg
Rheumatoid Arthritis
Mebeverine+Simethicone
Functional Bowel Disorder
Divalproex Sodium (Depakote ER)
Bipolar Disorder
ABT-335
Coronary Artery Disease
Lupron (leuprolide acetate)
Puberty, Precocious
Dydrogesterone 30 mg
Female Infertility
Racecadotril plus ORS
Diarrhea, Infantile
sibutramine
Binge Eating Disorder
Palivizumab
Respiratory Syncytial Virus Infection
Nelfinavir mesylate
HIV Infections
Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks
Psoriasis
lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs)
Human Immunodeficiency Virus Infections
paricalcitol capsules
End Stage Renal Disease
Sibutramine hydrochloride
Obesity
Micronized Progesterone 600 mg
Female Infertility
Hydrocodone/Acetaminophen Extended-Release
Pain
Hydrocodone/Acetaminophen Extended Release
Pain
atrasentan hydrochloride
Prostate Cancer
Divalproex Sodium (Depakote Sprinkle Capsules)
Partial Seizures
MTX
Psoriasis
Atrasentan
Prostate Cancer
Lamivudine
HIV Infections
lopinavir/ritonavir (LPV/r)
Human Immunodeficiency Virus Infection
Pancreatin
Pancreatic Insufficiency
fenofibrate
Hyperlipidemia
Eprosartan
Essential Hypertension
Adalimumab 40 mg subcutaneous (SC) every other week (EOW)
Rheumatoid Arthritis
Leuprolide acetate 11.25 mg
Puberty, Precocious
ABT-267
Chronic Hepatitis C
paricalcitol capsule
Renal Insufficiency, Chronic
ABT-450/ritonavir
Hepatitis C
ABT-333
HCV Infection
Ademetionine IV+tablet
Intrahepatic Cholestasis Associated With Alcoholic Liver Disease
Leuprolide acetate - Formulation A
Prostate Cancer
Divalproex Sodium Extended-Release Tablets
Schizophrenia
SAMe 1000 mg
Non Alcoholic Fatty Liver Disease
hydrocodone / acetaminophen extended release
Osteoarthritis
dobutamine
Acute Heart Failure
Tenofovir DF
HIV Infection
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
Human Immunodeficiency Virus Infections
Creon®
Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Phleum pratense grass pollen allergen extract
Seasonal Allergic Rhinitis
SA-001
Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Niacin ER/Simvastatin Tablets
Hyperlipidemia
cefdinir
Acute Otitis Media
Nevirapine
HIV Infections
Humira (adalimumab)
Psoriasis
rosuvastatin calcium
Mixed Dyslipidemia
Maxacalcitol
Chronic Kidney Disease on Hemodialysis
Hydrocodone/Acetaminophen on Extended Release
Moderate to Severe Chronic, Non-malignant Pain
DB adalimumab 40 mg eow
Crohn's Disease
Clarithromycin
Acute Bacterial Sinusitis (ABS)
adalimumab (Humira)
Ankylosing Spondylitis
Mitizax
Allergy
Amprenavir/ritonavir
HIV Infections
verapamil/trandolapril
Obesity
Leuprolide Acetate 3 Month Depot
Precocious
Influenza Vaccine
Influenza
ORS
Diarrhea
Saquinavir/ritonavir
HIV Infections
aspirin (ASA)
Dyslipidemia
Fixed Combination of Fenofibrate/simvastatin 145/20 mg
Dyslipidemia
adalimumab
Chronic Plaque Psoriasis
Adalimumab 40 mg eow or ew
Crohn's Disease
Double-blind adalimumab
Rheumatoid Arthritis
ABT-712
Chronic Low Back Pain
ABT-335 and rosuvastatin calcium
Dyslipidemia
Human anti-TNF monoclonal antibody/adalimumab
Psoriatic Arthritis
paricalcitol
End-Stage Renal Disease
divalproex sodium
Migraine
Extended release hydrocodone and acetaminophen (Vicodin CR)
Chronic Low Back Pain
Elagolix
Heavy Uterine Bleeding
ABT-450/r/ABT-267, ABT-333
Chronic Hepatitis C Infection
Trivalent influenza subunit vaccine Influvac
Influenza
adalimumab (D2E7)
Ankylosing Spondylitis
Testosterone (T) Gel 1.62%
Hypogonadism
ABT-874
Psoriasis
Levosimendan
Heart Failure, Congestive
Itopride Hydrochloride 150 mg extended release tablets
Functional Dyspepsia
OLE BSA Adalimumab +/- MTX
Arthritis, Juvenile Idiopathic
etanercept
Plaque Psoriasis
lamivudine/zidovudine
HIV Infection
Dydrogesterone
Recurrent Miscarriage
ABT-263
Small Cell Lung Cancer
ABT-288 Low Dose
Cognitive Deficits in Schizophrenia
Volociximab
Pancreatic Cancer
ABT-639
Diabetic Neuropathic Pain
Adalimumab, current formulation
Rheumatoid Arthritis
ABT-126
Cognitive Deficits in Schizophrenia
Extended-Release Hydrocodone/Acetaminophen
Pain
0.25 mg Atrasentan QD
Chronic Kidney Disease
Atrasentan low dose group
Chronic Kidney Disease
ABT-089
Attention-Deficit/Hyperactivity Disorder
ABT-751
Renal Cell Cancer
Cell-Derived Trivalent Subunit Influenza Vaccine
Influenza
Saquinavir mesylate
HIV Infections
ABT-450/ritonavir, ABT-267
Chronic Hepatitis C Infection
ABT-874/Human monoclonal antibody against IL-12
Multiple Sclerosis
Peginterferon alpha-2a
Hepatitis C
Zemplar (paricalcitol ) capsules
Diabetic Nephropathy
paricalcitol injection (Zemplar)
Hypocalcemia
Efavirenz
HIV Infections
M200 (Volociximab)
Ovarian Cancer, Primary Peritoneal Cancer
ABT-072
Hepatitis C
pegylated interferon alpha-2a (pegIFN)
Chronic Hepatitis C
NBI-56418 (GnRH antagonist)
Endometriosis
Veliparib
Brain Metastases From Non-small Cell Lung Cancer
Anti IL-12 monoclonal antibody/ABT-874
Psoriasis
Pegylated interferon
Chronic Hepatitis C Virus Infection
Navitoclax
Chronic Lymphocytic Leukemia
Choline Fenofibrate
Diabetic Macular Edema
ABT-384
Alzheimer's Disease
ABT-652 NSAID
Osteoarthritis of the Knee
Depakote Delayed-Release/Depakote Sprinkle
Pediatric Epilepsy
Kaletra® (lopinavir/ritonavir)
HIV Infections
ABT-652
Osteoarthritis of the Knee
ABT-SLV187
Advanced Parkinson's Disease
ABT-450/r
Hepatitis C, Chronic
ABT-712 Extended-release
Pain
ABT-869
Advanced or Metastatic Non-Small Cell Lung Cancer
(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400
Dry Eye
ABT-869 .25 mg/kg
Non-Small Cell Lung Cancer (NSCLC)
Asoprisnil/Premarin
Amenorrhea
New formulation adalimumab
Rheumatoid Arthritis
ABT-510/Thrombospondin-1 mimetic
Carcinoma, Renal Cell
ABT-510 - Thrombospondin-1 mimetic
Sarcoma, Soft Tissue
Creon IR
Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
ABT-894
Attention-Deficit/Hyperactivity Disorder
ABT-888
Ovarian Cancer
ABT-450
Chronic Hepatitis C Infection
ABT-288
Alzheimer's Disease
Itopride HCI 50 mg
Irritable Bowel Syndrome
SLV337
Type 2 Diabetes
elotuzumab
Hematologic Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Niacin extended-release (NER) | Phase 3 | Dyslipidemia | - | - |
Zemplar Capsule | Phase 3 | Kidney Disease | - | - |
clarithromycin extended-release tablets | Phase 3 | Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). | - | - |
Ritonavir | Phase 3 | Sarcoma, Kaposi | - | - |
Lopinavir/ritonavir | Phase 3 | HIV Infections | - | - |
Asoprisnil | Phase 3 | Uterine Fibroids | - | - |
Adalimumab 80 mg | Phase 3 | Rheumatoid Arthritis | - | - |
Mebeverine+Simethicone | Phase 3 | Functional Bowel Disorder | - | - |
Divalproex Sodium (Depakote ER) | Phase 3 | Bipolar Disorder | - | - |
ABT-335 | Phase 3 | Coronary Artery Disease | - | - |
Lupron (leuprolide acetate) | Phase 3 | Puberty, Precocious | - | - |
Dydrogesterone 30 mg | Phase 3 | Female Infertility | - | - |
Racecadotril plus ORS | Phase 3 | Diarrhea, Infantile | - | - |
sibutramine | Phase 3 | Binge Eating Disorder | - | - |
Palivizumab | Phase 3 | Respiratory Syncytial Virus Infection | - | - |
Nelfinavir mesylate | Phase 3 | HIV Infections | - | - |
Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks | Phase 3 | Psoriasis | - | - |
lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs) | Phase 3 | Human Immunodeficiency Virus Infections | - | - |
paricalcitol capsules | Phase 3 | End Stage Renal Disease | - | - |
Sibutramine hydrochloride | Phase 3 | Obesity | - | - |
Micronized Progesterone 600 mg | Phase 3 | Female Infertility | - | - |
Hydrocodone/Acetaminophen Extended-Release | Phase 3 | Pain | - | - |
Hydrocodone/Acetaminophen Extended Release | Phase 3 | Pain | - | - |
atrasentan hydrochloride | Phase 3 | Prostate Cancer | - | - |
Divalproex Sodium (Depakote Sprinkle Capsules) | Phase 3 | Partial Seizures | - | - |
MTX | Phase 3 | Psoriasis | - | - |
Atrasentan | Phase 3 | Prostate Cancer | - | - |
Lamivudine | Phase 3 | HIV Infections | - | - |
lopinavir/ritonavir (LPV/r) | Phase 3 | Human Immunodeficiency Virus Infection | - | - |
Pancreatin | Phase 3 | Pancreatic Insufficiency | - | - |
fenofibrate | Phase 3 | Hyperlipidemia | - | - |
Eprosartan | Phase 3 | Essential Hypertension | - | - |
Adalimumab 40 mg subcutaneous (SC) every other week (EOW) | Phase 3 | Rheumatoid Arthritis | - | - |
Leuprolide acetate 11.25 mg | Phase 3 | Puberty, Precocious | - | - |
ABT-267 | Phase 3 | Chronic Hepatitis C | - | - |
paricalcitol capsule | Phase 3 | Renal Insufficiency, Chronic | - | - |
ABT-450/ritonavir | Phase 3 | Hepatitis C | - | - |
ABT-333 | Phase 3 | HCV Infection | - | - |
Ademetionine IV+tablet | Phase 3 | Intrahepatic Cholestasis Associated With Alcoholic Liver Disease | - | - |
Leuprolide acetate - Formulation A | Phase 3 | Prostate Cancer | - | - |
Divalproex Sodium Extended-Release Tablets | Phase 3 | Schizophrenia | - | - |
SAMe 1000 mg | Phase 3 | Non Alcoholic Fatty Liver Disease | - | - |
hydrocodone / acetaminophen extended release | Phase 3 | Osteoarthritis | - | - |
dobutamine | Phase 3 | Acute Heart Failure | - | - |
Tenofovir DF | Phase 3 | HIV Infection | - | - |
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) | Phase 3 | Human Immunodeficiency Virus Infections | - | - |
Creon® | Phase 3 | Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis | - | - |
Phleum pratense grass pollen allergen extract | Phase 3 | Seasonal Allergic Rhinitis | - | - |
SA-001 | Phase 3 | Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | - | - |
Niacin ER/Simvastatin Tablets | Phase 3 | Hyperlipidemia | - | - |
cefdinir | Phase 3 | Acute Otitis Media | - | - |
Nevirapine | Phase 3 | HIV Infections | - | - |
Humira (adalimumab) | Phase 3 | Psoriasis | - | - |
rosuvastatin calcium | Phase 3 | Mixed Dyslipidemia | - | - |
Maxacalcitol | Phase 3 | Chronic Kidney Disease on Hemodialysis | - | - |
Hydrocodone/Acetaminophen on Extended Release | Phase 3 | Moderate to Severe Chronic, Non-malignant Pain | - | - |
DB adalimumab 40 mg eow | Phase 3 | Crohn's Disease | - | - |
Clarithromycin | Phase 3 | Acute Bacterial Sinusitis (ABS) | - | - |
adalimumab (Humira) | Phase 3 | Ankylosing Spondylitis | - | - |
Mitizax | Phase 3 | Allergy | - | - |
Amprenavir/ritonavir | Phase 3 | HIV Infections | - | - |
verapamil/trandolapril | Phase 3 | Obesity | - | - |
Leuprolide Acetate 3 Month Depot | Phase 3 | Precocious | - | - |
Influenza Vaccine | Phase 3 | Influenza | - | - |
ORS | Phase 3 | Diarrhea | - | - |
Saquinavir/ritonavir | Phase 3 | HIV Infections | - | - |
aspirin (ASA) | Phase 3 | Dyslipidemia | - | - |
Fixed Combination of Fenofibrate/simvastatin 145/20 mg | Phase 3 | Dyslipidemia | - | - |
adalimumab | Phase 3 | Chronic Plaque Psoriasis | - | - |
Adalimumab 40 mg eow or ew | Phase 3 | Crohn's Disease | - | - |
Double-blind adalimumab | Phase 3 | Rheumatoid Arthritis | - | - |
ABT-712 | Phase 3 | Chronic Low Back Pain | - | - |
ABT-335 and rosuvastatin calcium | Phase 3 | Dyslipidemia | - | - |
Human anti-TNF monoclonal antibody/adalimumab | Phase 3 | Psoriatic Arthritis | - | - |
paricalcitol | Phase 3 | End-Stage Renal Disease | - | - |
divalproex sodium | Phase 3 | Migraine | - | - |
Extended release hydrocodone and acetaminophen (Vicodin CR) | Phase 3 | Chronic Low Back Pain | - | - |
Elagolix | Phase 3 | Heavy Uterine Bleeding | - | - |
ABT-450/r/ABT-267, ABT-333 | Phase 3 | Chronic Hepatitis C Infection | - | - |
Trivalent influenza subunit vaccine Influvac | Phase 3 | Influenza | - | - |
adalimumab (D2E7) | Phase 3 | Ankylosing Spondylitis | - | - |
Testosterone (T) Gel 1.62% | Phase 3 | Hypogonadism | - | - |
ABT-874 | Phase 3 | Psoriasis | - | - |
Levosimendan | Phase 3 | Heart Failure, Congestive | - | - |
Itopride Hydrochloride 150 mg extended release tablets | Phase 3 | Functional Dyspepsia | - | - |
OLE BSA Adalimumab +/- MTX | Phase 3 | Arthritis, Juvenile Idiopathic | - | - |
etanercept | Phase 3 | Plaque Psoriasis | - | - |
lamivudine/zidovudine | Phase 3 | HIV Infection | - | - |
Dydrogesterone | Phase 3 | Recurrent Miscarriage | - | - |
ABT-263 | Phase 2 | Small Cell Lung Cancer | - | - |
ABT-288 Low Dose | Phase 2 | Cognitive Deficits in Schizophrenia | - | - |
Volociximab | Phase 2 | Pancreatic Cancer | - | - |
ABT-639 | Phase 2 | Diabetic Neuropathic Pain | - | - |
Adalimumab, current formulation | Phase 2 | Rheumatoid Arthritis | - | - |
ABT-126 | Phase 2 | Cognitive Deficits in Schizophrenia | - | - |
Extended-Release Hydrocodone/Acetaminophen | Phase 2 | Pain | - | - |
0.25 mg Atrasentan QD | Phase 2 | Chronic Kidney Disease | - | - |
Atrasentan low dose group | Phase 2 | Chronic Kidney Disease | - | - |
ABT-089 | Phase 2 | Attention-Deficit/Hyperactivity Disorder | - | - |
ABT-751 | Phase 2 | Renal Cell Cancer | - | - |
Cell-Derived Trivalent Subunit Influenza Vaccine | Phase 2 | Influenza | - | - |
Saquinavir mesylate | Phase 2 | HIV Infections | - | - |
ABT-450/ritonavir, ABT-267 | Phase 2 | Chronic Hepatitis C Infection | - | - |
ABT-874/Human monoclonal antibody against IL-12 | Phase 2 | Multiple Sclerosis | - | - |
Peginterferon alpha-2a | Phase 2 | Hepatitis C | - | - |
Zemplar (paricalcitol ) capsules | Phase 2 | Diabetic Nephropathy | - | - |
paricalcitol injection (Zemplar) | Phase 2 | Hypocalcemia | - | - |
Efavirenz | Phase 2 | HIV Infections | - | - |
M200 (Volociximab) | Phase 2 | Ovarian Cancer, Primary Peritoneal Cancer | - | - |
ABT-072 | Phase 2 | Hepatitis C | - | - |
pegylated interferon alpha-2a (pegIFN) | Phase 2 | Chronic Hepatitis C | - | - |
NBI-56418 (GnRH antagonist) | Phase 2 | Endometriosis | - | - |
Veliparib | Phase 2 | Brain Metastases From Non-small Cell Lung Cancer | - | - |
Anti IL-12 monoclonal antibody/ABT-874 | Phase 2 | Psoriasis | - | - |
Pegylated interferon | Phase 2 | Chronic Hepatitis C Virus Infection | - | - |
Navitoclax | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
Choline Fenofibrate | Phase 2 | Diabetic Macular Edema | - | - |
ABT-384 | Phase 2 | Alzheimer's Disease | - | - |
ABT-652 NSAID | Phase 2 | Osteoarthritis of the Knee | - | - |
Depakote Delayed-Release/Depakote Sprinkle | Phase 2 | Pediatric Epilepsy | - | - |
Kaletra® (lopinavir/ritonavir) | Phase 2 | HIV Infections | - | - |
ABT-652 | Phase 2 | Osteoarthritis of the Knee | - | - |
ABT-SLV187 | Phase 2 | Advanced Parkinson's Disease | - | - |
ABT-450/r | Phase 2 | Hepatitis C, Chronic | - | - |
ABT-712 Extended-release | Phase 2 | Pain | - | - |
ABT-869 | Phase 2 | Advanced or Metastatic Non-Small Cell Lung Cancer | - | - |
(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 | Phase 2 | Dry Eye | - | - |
ABT-869 .25 mg/kg | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
Asoprisnil/Premarin | Phase 2 | Amenorrhea | - | - |
New formulation adalimumab | Phase 2 | Rheumatoid Arthritis | - | - |
ABT-510/Thrombospondin-1 mimetic | Phase 2 | Carcinoma, Renal Cell | - | - |
ABT-510 - Thrombospondin-1 mimetic | Phase 2 | Sarcoma, Soft Tissue | - | - |
Creon IR | Phase 2 | Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis | - | - |
ABT-894 | Phase 2 | Attention-Deficit/Hyperactivity Disorder | - | - |
ABT-888 | Phase 2 | Ovarian Cancer | - | - |
ABT-450 | Phase 2 | Chronic Hepatitis C Infection | - | - |
ABT-288 | Phase 2 | Alzheimer's Disease | - | - |
Itopride HCI 50 mg | Phase 2 | Irritable Bowel Syndrome | - | - |
SLV337 | Phase 2 | Type 2 Diabetes | - | - |
elotuzumab | Phase 2 | Hematologic Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in ABBOTT LABORATORIES's drug pipeline?→
CatalystAlert tracks 140 drug candidates in ABBOTT LABORATORIES's (ABT) pipeline across Phase 3, Phase 2. Its lead program is Niacin extended-release (NER) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ABBOTT LABORATORIES's next FDA catalyst?→
ABBOTT LABORATORIES's (ABT) next tracked catalyst is a Earnings expected October 21, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ABT biotech catalysts?→
Add ABT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ABBOTT LABORATORIES's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.